Status | Study |
Completed |
Study Name: Vargatef in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Ovarian Cancer Condition: Ovarian Cancer Date: 2012-04-19 Interventions: Drug: vargatef |
Not yet recruiting |
Study Name: Biomarkers in Blood and Tissue Samples From Patients With Uterine Cancer Condition: Endometrial Serous Adenocarcinoma Stage I Uterine Corpus Cancer Date: 2011-04-28 Interventions: Other: Diagnostic Laboratory Biomarker Analysis |
Completed |
Study Name: Phase II ABT-888 With Cyclophosphamide Condition: Ovarian Cancer Primary Peritoneal Cancer Date: 2011-02-26 Interventions: Drug: ABT-888 PARP enzymes are |
Completed |
Study Name: Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors Condition: Endometrial Papillary Serous Carcinoma Recurrent Endometrial Ca Date: 2010-09-08 Interventions: Drug: temsirolimus Given IV or |
Completed |
Study Name: Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer Condition: Endometrial Adenocarcinoma Endometrial Adenosquamous Carcinoma Date: 2010-05-27 Interventions: Drug: Cediranib Maleate Given |
Active, not recruiting |
Study Name: Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Condition: Endometrial Clear Cell Adenocarcinoma Endometrial Serous Adenocarcinom Date: 2009-07-17 Interventions: Drug: Carboplatin Given IV |
Completed |
Study Name: Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System Condition: Ovarian Cancer Date: 2009-02-05 |
Active, not recruiting |
Study Name: Selumetinib in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer Condition: Borderline Ovarian Surface Epithelial-stromal Tumor Ovarian Serous Cys Date: 2007-10-22 Interventions: Drug: selumetinib Given PO |
Completed |
Study Name: Papillary Serous Carcinoma of the Endometrium Condition: Endometrial Cancer Date: 2007-08-09 Interventions: Drug: Paclitaxel 50 mg/m^2 IV |
Completed |
Study Name: Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma Condition: Uterine Cancer Date: 2007-07-23 Interventions: Drug: Imatinib Mesylate |